Continuous Glucose Monitoring Devices Market Set for Steady Growth to USD 10.72 Billion by 2033, Led by North America's 39% Global Market Share | DataM Intelligence

The Global Continuous Glucose Monitoring (CGM) Devices Market was valued at USD 5.24 billion in 2023 and increased to USD 5.61 billion in 2024. It is projected to reach USD 10.72 billion by 2033, growing at a steady CAGR of 8.1% during 2025-2033.

Market growth is driven by the rising prevalence of diabetes, increasing adoption of real-time glucose monitoring technologies, and strong demand for minimally invasive and user-friendly devices. Advancements in sensor accuracy, smartphone integration, and continuous patient monitoring are further accelerating market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/continuous-glucose-monitoring-devices-market?ram

United States: Key Industry Developments
✅ November 2025: Dexcom announced an upgrade to its G7 continuous glucose monitoring system, featuring improved sensor longevity and enhanced integration with popular insulin pumps for better user convenience and accuracy in diabetes management.

✅ September 2025: Abbott launched the FreeStyle Libre 4, a next-generation CGM with extended sensor wear time, factory calibration, and real-time data sharing to improve usability for Type 1 and Type 2 diabetes patients.

✅ June 2025: Medtronic released the Guardian Connect 2 CGM system, incorporating AI-powered predictive alerts to prevent hypo- and hyperglycemic events while offering improved sensor accuracy and smartphone connectivity.

Europe: Key Industry Developments
✅ May 2025: Roche announced a $550 million investment to expand its continuous glucose monitoring systems manufacturing hub, aimed at providing innovative diabetes monitoring solutions and boosting production capacity.

Key Merges and Acquisitions(2025):
✅ Philips launches AI-powered medical devices (Indirect Impact): At RSNA 2025 in December, Philips launched new AI-powered CT and MRI systems. The general trend towards AI integration in diagnostics influences the CGM market, where AI-powered platforms are increasingly used for predictive analytics and personalized health insights based on continuous glucose data.

✅ Dexcom receives FDA nod for 15-day CGM: Dexcom achieved a high point in 2025 with an FDA clearance for its next-generation 15-day CGM sensor. This technological advancement enhances user convenience and is expected to contribute to future margin expansion. .

✅ Senseonics signs MOU with Ascensia Diabetes Care to take over commercialization: In September 2025, Senseonics signed a Memorandum of Understanding to fully transition all commercialization and distribution of the Eversense 365 and future products from its partner, Ascensia Diabetes Care, to Senseonics directly.

Market Segmentation Analysis:
-By Component
Sensors lead with 52.4% market share in 2024-2025, driven by their accuracy in real-time glucose tracking and frequent replacement needs (7-14 days for disposables).
Transmitters and receivers follow with smaller shares, enabling wireless data transmission from sensors to displays or apps, boosted by integration in compact systems.
Sensors dominate due to technological advancements improving affordability and performance in diverse settings.

-By Connectivity
Bluetooth holds the largest share as the primary wireless standard for CGM devices, offering reliable short-range data transfer to smartphones and receivers.
Wi-Fi supports longer-range connectivity for cloud syncing and remote monitoring, growing with 4G/5G integrations but trailing Bluetooth in adoption.
Bluetooth leads for its seamless integration and low power use in homecare.

-By Application
Type 1 Diabetes commands the top share at around 60%, fueled by the need for constant monitoring in insulin-dependent patients.
Type 2 Diabetes follows with rising prevalence, using CGM for lifestyle management; Gestational and Prediabetes segments are smaller but expanding via accessibility.
Type 1 Diabetes is the leading segment from high usage volumes.

-By End-User
Homecare settings dominate with over 50% share, empowered by user-friendly wearables and apps for daily self-monitoring.
Hospitals & Clinics and Diagnostic Centers hold significant portions for professional oversight; Others include specialized uses.
Homecare leads due to patient preference for convenience and cost savings.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=continuous-glucose-monitoring-devices-market?ram (Purchase 2 or more Reports and get 50% Discount)

Growth Drivers:
-Rising global prevalence of diabetes driven by aging population, sedentary lifestyles, obesity, and hereditary factors increasing demand for CGM devices.

-Continuous technological advancements improving sensor accuracy, wear duration, and integration with digital health platforms and insulin delivery systems.

-Increasing awareness about the benefits of real-time glucose monitoring and tighter glycemic control in diabetes management.

-Expanded regulatory endorsements, reimbursement frameworks, and government initiatives supporting wider access and adoption of CGM devices.

-Growth opportunities in emerging markets, especially in the Asia Pacific region, due to rising healthcare expenditure, urbanization, and increasing diabetes awareness.

Regional Insights:
-The North American market holds the largest share in the Continuous Glucose Monitoring Devices Market, with approximately 39% market share as of 2024. This dominance is driven by robust healthcare infrastructure, advanced technology adoption, and strong awareness of diabetes management in the region. North America is expected to continue leading in terms of revenue through the forecast period.

-Next in line is the Europe market, which shows significant growth due to supportive healthcare policies, reimbursement frameworks, and technological advancements in diabetes care, especially in countries like Germany, the UK, and France. The European Union overall has a Compound Annual Growth Rate (CAGR) of around 12.9% from 2025 to 2035 and holds a considerable market share, though smaller than North America.

-The Asia Pacific region is the fastest-growing market for continuous glucose monitoring devices, with a market share estimated to be around 8.1% in 2024. It is projected to grow rapidly with a CAGR close to or above 15% during the forecast period, driven by increased diabetes prevalence, aging population, and rising healthcare investments in countries like Japan, South Korea, China, and India. However, its current market share is less than that of North America and Europe but is rapidly expanding.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/continuous-glucose-monitoring-devices-market?ram

Key Players:
Abbott Laboratories | Medtronic Plc | Medtrum Technologies Inc | Biolinq Incorporated | Dexcom, Inc. | A. Menarini Diagnostics S.r.l. | Ypsomed AG | Senseonics Holdings, Inc. | Nemaura | LifeScan IP Holdings, LLC

Key Highlights (Top 5 Key Players) for Continuous Glucose Monitoring Devices Market:
-Dexcom, Inc. leads the CGM sector with strong market positioning through innovative sensor technologies and expansions in connectivity features.​

-Abbott Laboratories drives significant growth via its FreeStyle Libre platform, capturing major share in sensor-based monitoring solutions.​

-Medtronic Plc reported USD 2.76 billion in Diabetes segment revenue for fiscal 2025, up 10.73% year-over-year, including CGM-integrated insulin delivery systems.​

-Senseonics Holdings, Inc. advances implantable CGM devices like Eversense, focusing on long-term continuous monitoring adoption.​

-A. Menarini Diagnostics S.r.l. contributes through partnerships and distribution of advanced CGM systems in Europe and emerging markets.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.